Simvastatin-romidepsin combination kills bladder cancer cells synergistically.

Okubo, Kazuki; Miyai, Kosuke; Kato, Kimi; Asano, Takako; Sato, Akinori

Okubo, Kazuki; Miyai, Kosuke; Kato, Kimi; Asano, Takako; Sato, Akinori.

Afiliação

Okubo K; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
Miyai K; Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Kato K; Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Asano T; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
Sato A; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. Electronic address: zenpaku@ndmc.ac.jp.

Transl Oncol ; 14(9): 101154, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34144348

Palavras-chave

AMP-activated protein kinase (AMPK); Endoplasmic reticulum (ER) stress; Histone acetylation; Peroxisome proliferator-activated receptor (PPAR) Î³; Romidepsin; Simvastatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article